{"DataElement":{"publicId":"2182540","version":"1","preferredName":"Surgical Margin Resection Status","preferredDefinition":"the field to describe the histologic information regarding the pathology status of the surgical margins of resection.","longName":"SURG_MARG_RES_STAT","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2197799","version":"1","preferredName":"Surgical Margin Resection","preferredDefinition":"information related to the surgical margin following resection.","longName":"SURG_MARG_RES","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2660130","version":"1","preferredName":"Surgical Surgical Margin","preferredDefinition":"of or relating to or involving or used in surgery or requiring or amenable to treatment by surgery.:The edge or border of the tissue removed in cancer surgery.  The margin is described as negative or clean when the pathologist finds no cancer cells at the edge of the tissue, suggesting that all of the cancer has been removed.  The margin is described as positive or involved when the pathologist finds cancer cells at the edge of the tissue, suggesting that all of the cancer has not been removed.","longName":"C25698:C41227","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Surgical","conceptCode":"C25698","definition":"of or relating to or involving or used in surgery or requiring or amenable to treatment by surgery.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Surgical Margin","conceptCode":"C41227","definition":"One of the criteria for assessment of the effectiveness of given surgical procedure in achieving the local control of a neoplasm and the adequacy of tumor removal. It is defined by the tissue plane through which the dissection has been done and the actual or potential neoplastic tissue which has been left outside the boundary of a resected specimen within the patient. There are four types of surgical margins: intracapsular or intralesional, marginal, wide, and radical.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"33DA6504-03BB-121A-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-26","endDate":null,"createdBy":"SBREXT","dateCreated":"2007-06-26","modifiedBy":"ONEDATA","dateModified":"2007-06-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2177334","version":"1","preferredName":"Resection","preferredDefinition":"(ree-SEK-shun) Removal of tissue or part or all of an organ by surgery.","longName":"Resection","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Excision","conceptCode":"C15232","definition":"The surgical removal of a lesion, often as part of a biopsy and with healthy margins.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE29A78C-528A-3A05-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EF0DDC55-0520-33DF-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-01","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-02-01","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Updated to associate with Surgical Margin OC instead of post-coordinated surgical + margin, surgical was retired EVS concept","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2182538","version":"1","preferredName":"Surgical Margin Resection Status","preferredDefinition":"information related to the status of surgical margins following resection.","longName":"SURG_MARG_RES_STAT","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"2","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"R0","valueDescription":"All Margins Pathologically Negative","ValueMeaning":{"publicId":"2558208","version":"1","preferredName":"All Margins Pathologically Negative","longName":"2558208","preferredDefinition":"Indicates the absence of tumor cells at the edge of a surgically excised specimen.: Cancer cells that remain after attempts to remove the cancer have been made.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negative Surgical Margin","conceptCode":"C48621","definition":"Indicates the absence of tumor cells at the edge of a surgically excised specimen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Residual Disease","conceptCode":"C4809","definition":"Tumor cells that remain in the body following cancer treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B06D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"COOPERM","dateModified":"2016-12-19","changeDescription":"Concept annotation added for UPitt/TCGA.  Ylu, 02/19/2015. Changed all uppercase Long Name to capitalize each word. mc 12/19/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D71B7F7E-D238-6A1C-E034-0003BA12F5E7","beginDate":"2004-04-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-04-02","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"R1","valueDescription":"Microscopically Positive Margins or Microscopic Residual Disease","ValueMeaning":{"publicId":"2559219","version":"1","preferredName":"Microscopically Positive Margins or Microscopic Residual Disease","longName":"2559219","preferredDefinition":"Indicates the presence of tumor cells at the edge of a surgically excised specimen.: A finding resulting from the examination of a tissue sample under light or electron microscopy.: Cancer cells that remain after attempts to remove the cancer have been made.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Positive Surgical Margin","conceptCode":"C48620","definition":"Indicates the presence of tumor cells at the edge of a surgically excised specimen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Histopathology Result","conceptCode":"C83490","definition":"A finding resulting from the examination of a tissue sample under light or electron microscopy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Residual Disease","conceptCode":"C4809","definition":"Tumor cells that remain in the body following cancer treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B460-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"COOPERM","dateModified":"2016-12-19","changeDescription":"Concept annotation added for UPitt/TCGA.  Ylu, 02/19/2015. Changed all uppercase Long Name to capitalize each word. mc 12/19/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D71B7F7E-D23C-6A1C-E034-0003BA12F5E7","beginDate":"2004-04-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-04-02","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"R2","valueDescription":"Macroscopically Positive Margins or Gross Residual Disease","ValueMeaning":{"publicId":"2559141","version":"1","preferredName":"Macroscopically Positive Margins or Gross Residual Disease","longName":"2559141","preferredDefinition":"The presence of macroscopically visible residual tumor at the edge of a surgically excised specimen.: Visible to the naked eye.: Cancer cells that remain after attempts to remove the cancer have been made.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Macroscopically Positive Surgical Margin","conceptCode":"C120274","definition":"The presence of macroscopically visible residual tumor at the edge of a surgically excised specimen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Gross","conceptCode":"C43566","definition":"Visible to the naked eye.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Residual Disease","conceptCode":"C4809","definition":"Tumor cells that remain in the body following cancer treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B412-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"COOPERM","dateModified":"2016-12-19","changeDescription":"Concept annotation added for UPitt/TCGA.  Ylu, 02/19/2015. Changed all uppercase Long Name to capitalize each word. mc 12/19/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D71B7F7E-D240-6A1C-E034-0003BA12F5E7","beginDate":"2004-04-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-04-02","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"RX","valueDescription":"Presence of Residual Disease Cannot Be Assessed","ValueMeaning":{"publicId":"2559858","version":"1","preferredName":"Presence of Residual Disease Cannot Be Assessed","longName":"2559858","preferredDefinition":"Cancer cells that remain after attempts to remove the cancer have been made.: Being or existing in a specified place or at the specified time.: Aspects of the context prevent the evaluation needed to determine a value.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Residual Disease","conceptCode":"C4809","definition":"Tumor cells that remain in the body following cancer treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Present","conceptCode":"C25626","definition":"Being or existing in a specified place or at the specified time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Cannot Be Assessed","conceptCode":"C48657","definition":"Aspects of the context prevent the evaluation needed to determine a value.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B6DF-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"COOPERM","dateModified":"2016-12-19","changeDescription":"Concept annotation added for UPitt/TCGA.  Ylu, 02/19/2015. Changed all uppercase Long Name to capitalize each word. mc 12/19/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E21A05E0-DC21-71EB-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2004-08-20","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"R0.5","valueDescription":"R0.5","ValueMeaning":{"publicId":"2611814","version":"1","preferredName":"R0.5","longName":"2611814","preferredDefinition":"All margins pathologically negative, except for thrombus (positive margin) at renal vein","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2B91A989-B820-7074-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-03-13","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-03-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2B91AB6C-089C-703D-E044-0003BA3F9857","beginDate":"2007-03-13","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-03-13","modifiedBy":"ONEDATA","dateModified":"2007-03-13","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008563","version":"1","preferredName":"Therapy Results","preferredDefinition":"the results or effects (does not include CTC Adverse Events) of therapeutic agents or procedures administered to the patient.","longName":"TX_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6690D31-4081-494A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-01-06","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-02-11","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2184340","version":"1","preferredName":"Status","preferredDefinition":"Status; a condition or state at a particular time.","longName":"Status","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB6C8AC6-20AD-3E75-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2004-05-27","modifiedBy":"SBR","dateModified":"2005-04-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D71B2E6B-CACA-5F0A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-04-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-04-02","modifiedBy":"COOPERM","dateModified":"2016-12-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"10000607","version":"1","longName":"Sarcoma","context":"CTEP"},{"publicId":"2811832","version":"1","longName":"Lung","context":"CTEP"},{"publicId":"2811871","version":"1","longName":"Colorectal","context":"CTEP"},{"publicId":"2812017","version":"1","longName":"Phase II Lung Cancer","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811963","version":"1","longName":"Treatment","context":"CTEP"}]},{"publicId":"2008594","version":"2.31","longName":"Trial Type Usages (CDE Disease Committees)","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811884","version":"1","longName":"Adult STS New","context":"CTEP"},{"publicId":"2811885","version":"1","longName":"Adult STS Recurrent","context":"CTEP"},{"publicId":"10000027","version":"1","longName":"Bone Sarcoma New","context":"CTEP"},{"publicId":"10000028","version":"1","longName":"Bone Sarcoma Recur","context":"CTEP"},{"publicId":"2811886","version":"1","longName":"Ped STS New","context":"CTEP"},{"publicId":"2811889","version":"1","longName":"Ped STS Recurrent","context":"CTEP"},{"publicId":"2811810","version":"1","longName":"NSCLC 2nd Line","context":"CTEP"},{"publicId":"10000001","version":"1","longName":"NSCLC Advanced","context":"CTEP"},{"publicId":"2811931","version":"1","longName":"NSCLC Stage I-III","context":"CTEP"},{"publicId":"2811821","version":"1","longName":"SCLC 2nd Line","context":"CTEP"},{"publicId":"2811822","version":"1","longName":"SCLC Extensive","context":"CTEP"},{"publicId":"2811823","version":"1","longName":"SCLC Limited","context":"CTEP"}]},{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2812367","version":"1","longName":"caBIG","context":"CCR"}]},{"publicId":"2008608","version":"1","longName":"Phase","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811891","version":"1","longName":"Phase II","context":"CTEP"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]},{"publicId":"2183535","version":"1","longName":"Clinical Trial Mgmt Systems","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812831","version":"1","longName":"Oregon Health & Sciences University","context":"NCIP"},{"publicId":"2812832","version":"1","longName":"OHSU_288","context":"NCIP"},{"publicId":"2812625","version":"1","longName":"CTMS C3D Adopter Sites","context":"NCIP"},{"publicId":"2812205","version":"1","longName":"Arizona Cancer Center","context":"NCIP"},{"publicId":"2812575","version":"1","longName":"AZCC 0210","context":"NCIP"}]},{"publicId":"4057943","version":"1","longName":"Disease Site","context":"NRG","ClassificationSchemeItems":[{"publicId":"4171061","version":"1","longName":"RTOG-1010","context":"NRG"},{"publicId":"4171060","version":"1","longName":"RTOG-0848","context":"NRG"}]}],"AlternateNames":[{"name":"SURG_MARG_RES_STAT","type":"C3D Name","context":"NCIP"},{"name":"caBIG","type":"USED_BY","context":"NCIP"},{"name":"CCR","type":"USED_BY","context":"CCR"},{"name":"63959","type":"HISTORICAL_CDE_ID","context":"CTEP"},{"name":"65394","type":"HISTORICAL_CDE_ID","context":"CTEP"},{"name":"SURG_MARG_RES_STAT","type":"USED_BY","context":"Alliance"},{"name":"SURG_MARG_RES_STAT","type":"USED_BY","context":"NRG"},{"name":"MI_MIORRES_SGMGSTAT_TES","type":"OID, CCTG","context":"CCTG"},{"name":"MI_MIORRES_SGMGSTAT_TME","type":"OID, CCTG","context":"CCTG"}],"ReferenceDocuments":[{"name":"Margins of surgical resection","type":"Preferred Question Text","description":"Margins of surgical resection","url":null,"context":"CTEP"},{"name":"CRF Text","type":"Alternate Question Text","description":"Surgical Margin Status ","url":null,"context":"CTEP"},{"name":"Surgical Margin","type":"Alternate Question Text","description":"Surgical Margin Resection Status","url":null,"context":"CTEP"},{"name":"CRF Text3","type":"Alternate Question Text","description":"Overall Margin Status","url":null,"context":"CTEP"},{"name":"CRF Text1","type":"Alternate Question Text","description":"Resection Classification","url":null,"context":"CTEP"},{"name":"CRF Text4","type":"Alternate Question Text","description":"Invasive margin status","url":null,"context":"Alliance"},{"name":"CRF Text5","type":"Alternate Question Text","description":"Resection status","url":null,"context":"Alliance"},{"name":"CCTG_01","type":"Alternate Question Text","description":"Resection status:","url":null,"context":"CCTG"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D71B7F7E-D232-6A1C-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-08-20","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-04-02","modifiedBy":"CLOHNES","dateModified":"2023-11-07","changeDescription":"merged 2 non-compliant elements with new Sarcoma element","administrativeNotes":"11/7/23 Added AQT and 2 alt OIDs for CCTG for ticket number CADSR0003018 cjl.","unresolvedIssues":null,"deletedIndicator":"No"}}